Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 211.97 -1.79 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $213.76 | 52 Week High | $160.00 | |||
| Open | $213.75 | 52 Week Low | $95.80 | |||
| Day High | $215.13 | P/E | 39.40 | |||
| Day Low | $211.53 | EPS | $5.38 | |||
| Volume | 695,908 | |||||
